336 related articles for article (PubMed ID: 26542362)
1. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
Masuda M; Sawa M; Yamada T
Pharmacol Ther; 2015 Dec; 156():1-9. PubMed ID: 26542362
[TBL] [Abstract][Full Text] [Related]
2. Emergence of TNIK inhibitors in cancer therapeutics.
Yamada T; Masuda M
Cancer Sci; 2017 May; 108(5):818-823. PubMed ID: 28208209
[TBL] [Abstract][Full Text] [Related]
3. Structural Insight into TNIK Inhibition.
Kukimoto-Niino M; Shirouzu M; Yamada T
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361804
[TBL] [Abstract][Full Text] [Related]
4. TNIK inhibition abrogates colorectal cancer stemness.
Masuda M; Uno Y; Ohbayashi N; Ohata H; Mimata A; Kukimoto-Niino M; Moriyama H; Kashimoto S; Inoue T; Goto N; Okamoto K; Shirouzu M; Sawa M; Yamada T
Nat Commun; 2016 Aug; 7():12586. PubMed ID: 27562646
[TBL] [Abstract][Full Text] [Related]
5. Targeting the Wnt signaling pathway in colorectal cancer.
Sawa M; Masuda M; Yamada T
Expert Opin Ther Targets; 2016; 20(4):419-29. PubMed ID: 26439805
[TBL] [Abstract][Full Text] [Related]
6. Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.
Shitashige M; Satow R; Jigami T; Aoki K; Honda K; Shibata T; Ono M; Hirohashi S; Yamada T
Cancer Res; 2010 Jun; 70(12):5024-33. PubMed ID: 20530691
[TBL] [Abstract][Full Text] [Related]
7. Liquidambaric acid inhibits Wnt/β-catenin signaling and colon cancer via targeting TNF receptor-associated factor 2.
Yan R; Zhu H; Huang P; Yang M; Shen M; Pan Y; Zhang C; Zhou X; Li H; Ke X; Zhang W; Hao P; Qu Y
Cell Rep; 2022 Feb; 38(5):110319. PubMed ID: 35108540
[TBL] [Abstract][Full Text] [Related]
8. The kinase TNIK is an essential activator of Wnt target genes.
Mahmoudi T; Li VS; Ng SS; Taouatas N; Vries RG; Mohammed S; Heck AJ; Clevers H
EMBO J; 2009 Nov; 28(21):3329-40. PubMed ID: 19816403
[TBL] [Abstract][Full Text] [Related]
9. Role of the Rap2/TNIK kinase pathway in regulation of LRP6 stability for Wnt signaling.
Park DS; Seo JH; Hong M; Choi SC
Biochem Biophys Res Commun; 2013 Jun; 436(2):338-43. PubMed ID: 23743195
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer and genetic alterations in the Wnt pathway.
Segditsas S; Tomlinson I
Oncogene; 2006 Dec; 25(57):7531-7. PubMed ID: 17143297
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
Cheng X; Xu X; Chen D; Zhao F; Wang W
Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
[TBL] [Abstract][Full Text] [Related]
12. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells.
Lee Y; Jung JI; Park KY; Kim SA; Kim J
Oncotarget; 2017 Jun; 8(25):41091-41101. PubMed ID: 28467797
[TBL] [Abstract][Full Text] [Related]
13. Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting.
Hankey W; Frankel WL; Groden J
Cancer Metastasis Rev; 2018 Mar; 37(1):159-172. PubMed ID: 29318445
[TBL] [Abstract][Full Text] [Related]
14. Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition (EMT).
Sun Y; Gao X; Wu P; Wink M; Li J; Dian L; Liang Z
Phytomedicine; 2019 Oct; 63():153015. PubMed ID: 31302315
[TBL] [Abstract][Full Text] [Related]
15. Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis.
Jin J; Jung HY; Wang Y; Xie J; Yeom YI; Jang JJ; Lee KB
Pathol Res Pract; 2014 Oct; 210(10):621-7. PubMed ID: 25160513
[TBL] [Abstract][Full Text] [Related]
16. Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells.
Chon HJ; Lee Y; Bae KJ; Byun BJ; Kim SA; Kim J
Amino Acids; 2016 Jul; 48(7):1591-9. PubMed ID: 26995282
[TBL] [Abstract][Full Text] [Related]
17. Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer.
Kim HA; Koo BK; Cho JH; Kim YY; Seong J; Chang HJ; Oh YM; Stange DE; Park JG; Hwang D; Kong YY
J Clin Invest; 2012 Sep; 122(9):3248-59. PubMed ID: 22863622
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors.
Ho KK; Parnell KM; Yuan Y; Xu Y; Kultgen SG; Hamblin S; Hendrickson TF; Luo B; Foulks JM; McCullar MV; Kanner SB
Bioorg Med Chem Lett; 2013 Jan; 23(2):569-73. PubMed ID: 23232060
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
20. Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK).
Ma L; Li R; Yao Z; Wang B; Liu Y; Liu C; Wang H; Chen S; Sun D
Aging (Albany NY); 2022 Oct; 14(20):8394-8410. PubMed ID: 36287174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
